Bausch + Lomb : Will Acquire XIIDRA®
Bausch + Lomb Will Acquire XIIDRA® Acquisition Represents Significant Opportunity for Growth in Prescription Dry Eye Segment VAUGHAN,...
Source: marketscreener.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Lomb Forward Looking. Real-time updates on events, politics, business and more.